Weekly Vet Report: Thousands of veterinary drugs recalled, FDA drug approval + more

Thousands of compounded veterinary medication listings are under recall over concerns about drug potency. This week’s veterinary news also includes the first confirmed New World screwworm detection in US wildlife since the parasite’s return and an FDA approval of a new injectable antibiotic formulation for dogs.

Wedgewood recalls thousands of compounded veterinary medications

Wedgewood Pharmacy is voluntarily recalling nearly 4000 compounded veterinary product listings because they may contain too much or too little active ingredient. Compounded medications are customized drugs prepared by a pharmacist or veterinarian to meet an animal’s specific needs.

The recall covers products shipped nationwide from February 18 through October 6, 2026, including oral medications, injectables, ophthalmic products, and topical treatments. According to the company, inconsistencies in laboratory testing data may have affected product potency.

To date, Wedgewood has received 98 complaints, including 7 it classified as serious. The company has not provided details about the complaints.

Veterinary practices and pharmacies should check inventory against Wedgewood’s online recall lookup, quarantine affected products, and contact the company. Practices that have dispensed affected products should identify and notify clients who received them. Pet owners should stop using affected products, retain them, and contact their veterinarian and Wedgewood’s recall services at 866-562-5931 for guidance on an alternative treatment.

New World screwworm detected in US wildlife

The US Department of Agriculture’s Animal and Plant Health Inspection Service (USDA APHIS) has confirmed New World screwworm in an elk harvested on a game ranch in Pecos County, Texas. It is the first confirmed detection in US wildlife since the parasite’s return.

Officials are urging hunters, landowners, and veterinary professionals to watch for larvae in wounds or body openings, open or foul-smelling wounds, and animals showing signs of distress. Suspected infestations in live or very recently deceased wildlife should be reported promptly.

FDA approves higher-concentration Convenia formulation for dogs

The FDA has approved Convenia RTU for Dogs, a higher-concentration, ready-to-use formulation of the injectable antibiotic cefovecin for certain bacterial skin infections, abscesses, and wounds.

The new formulation contains 160 mg/mL, twice the concentration of the original product, and can provide up to 14 days of treatment with a single injection.

Convenia RTU is approved for dogs only. Two inactive ingredients may be toxic to cats, so the product should not be used in felines.